Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Suicidality: early-phase trial registry

2 of 5 indexed Suicidality trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Suicidality: 5 US clinical trials tracked, 2 recruiting.

Suicidality is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is VA Eastern Colorado Health Care System, running 1 of these trials.

Enrollment posture brief

Registry condition suicidality

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Suicidality (this)40%
Open-enrollment share among volume-matched conditions near Suicidality

Suicidality lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Suicidality on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Suicidality is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Suicidality research.

    VA Eastern Colorado Health Care System accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Suicidality trials plan to enrol fewer than 100 people.

    Median target enrolment is 48 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Suicidality research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Suicidality records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CAMS Behavioral
1 trials
accelerated Thetaburst stimulation Device
1 trials
school-based intervention Behavioral
1 trials
Active Condition Behavioral
1 trials
Therapeutic Support Behavioral
1 trials
Treatment As Usual Other
1 trials
Sham Comparator Device
1 trials
Active Comparator Behavioral
1 trials

US sites by state

Facility locations filed on Suicidality trials. A trial with sites in several states counts in each.

California 2 trials
Texas 1 trials
Pennsylvania 1 trials
Ohio 1 trials
Georgia 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Suicidality page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Suicidality condition card totals 5 registered trials; most-linked intervention CAMS; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.